Ozeroff Christopher David 4
4 · ARCA biopharma, Inc. · Filed Oct 24, 2012
Insider Transaction Report
Form 4
Ozeroff Christopher David
EVP & General Counsel
Transactions
- Award
Common Stock Warrant (right to buy)
2012-10-22+47,606→ 47,606 totalExercise: $0.30From: 2012-10-25Exp: 2017-10-25→ Common Stock (47,606 underlying) - Award
Common Stock
2012-10-22$0.39/sh+63,475$25,003→ 105,233 total
Footnotes (1)
- [F1]The warrants are fully vested and exercisable upon issuance and have a contractual term of 5 years.